Management

Mike Blastick

President

Mr. Blastick joined ZOLL as President of the Cardiac Management Solutions division in April 2024. Prior to joining ZOLL, Mr. Blastick was President of Aesculap, a B. Braun Company. From 2006 to 2021, he worked in a variety of executive roles at Boston Scientific. Mr. Blastick holds an MBA from the Kellogg School of Management at Northwestern University and a bachelor’s degree in Accounting from Indiana University.
 

Leslie Cunningham

Vice President, Human Resources

Ms. Cunningham was named Vice President, Human Resources in November 2020, after serving as the Director, Human Resources. Before joining the company in 2012, she had over 15 years of human resources experience holding various leadership roles with Reed Smith LLP, HealthSouth Corporation and May Department Stores. Ms. Cunningham holds an MS in Human Resources Management from Robert Morris University and a BS in Labor & Industrial Relations from Penn State. She also maintains her SPHR and SCP-SHRM certifications.
 

Mike Gabrin

Vice President, Research and Development

Mr. Gabrin joined the Company in 2016. He comes to ZOLL with more than 20 years in senior leadership positions in technology and healthcare companies, most recently as the Chief Technology Officer and Chief Information Officer for Helomics Corporation (formerly Precision Therapeutics). He previously held the position of Chief Technology Officer & Vice President of Product Development for Vocollect (now Honeywell: Vocollect Voice Solutions). Mr. Gabrin received his BS in Electrical Engineering from the University of Pittsburgh.
 

Kim Tonelli

Vice President, Support Services

Ms. Tonelli joined the Company in 2007 and was promoted to Vice President of Support Services in 2024. During her tenure, she has served as Director of Technical Support and held various customer support leadership positions. Prior to joining ZOLL, she held a leadership position at a social service agency. Ms. Tonelli received her BA in Sociology from Slippery Rock University of Pennsylvania and her MS in Strategic Leadership from Mountain State University.
  

Sharon Kim

Vice President, Reimbursement

Ms. Kim joined the Company in 2012. She comes to ZOLL with more than 18 years of healthcare and reimbursement experience, most recently as Vice President, Corporate Development for Precision Therapeutics. She previously held business development and managerial positions at McKesson Corporation and Deloitte Consulting. She received her BA in Economics and MBA from Stanford University.
 

Bernard Komoroski, PharmD, PhD

Vice President, Product Marketing and Communications

Mr. Komoroski was named Vice President, Product Marketing and Communications in 2017 after serving as Director of Product Marketing since 2010. He has over 15 years of experience in academic research and pharmaceutical and medical device clinical development and marketing. Before joining ZOLL, he held various positions at Bristol-Myers Squibb in the commercialization of products in a range of therapeutic areas including neuroscience, metabolics, oncology, immunology and cardiology. Mr. Komoroski holds Doctorates in Pharmacy (PharmD) and Pharmaceutical Sciences (PhD) from the University of Pittsburgh.
 

Alexa Miller Hall

Vice President, US Sales

Ms. Miller Hall joined the Company in 2012, holding various sales leadership roles at ZOLL before being promoted to Vice President of US Sales in June 2021. Ms. Miller Hall has more than 20 years of sales and sales leadership experience, starting at Abbott Laboratories, and including multiple senior leadership roles in cardiac monitoring at CardioNet (now BioTel/Philips), and vice president roles at two healthcare information technology startups specializing in patient safety and clinical communication. Ms. Miller Hall has a B.S. in Communication Sciences and Disorders from Boston University and an M.S. in Communication Disorders from Baylor University.
 

Gene Partin

Vice President, Quality Assurance and Regulatory Affairs

Mr. Partin joined the Company in 1994 as a quality engineer. Since then, he has held increasing roles of responsibility in the quality and regulatory departments. Prior to joining the Company, he spent 14 years in various manufacturing and quality assurance roles at Contraves Goerz, a defense / aerospace contractor. Mr. Partin received technical training in Electronics.
 

Sean Rollman

Vice President, Finance and Administration, and Chief Financial Officer

Mr. Rollman joined the Company in 2011. He comes to ZOLL with more than 19 years experience designing and managing financial operations for growth-oriented technology, service, and manufacturing companies. Most recently, Mr. Rollman was the CFO for Plextronics, Inc., a company developing technologies for printed electronics. Prior to that, he spent 8 years with FreeMarkets & Ariba. He began his career in public accounting with Coopers & Lybrand. Mr. Rollman received a BS in Accounting and Economics from Indiana University of Pennsylvania.
 

Vinita Sinha

Vice President, Division General Counsel

Ms. Sinha joined the Company in 2019. She was Head of Global Commercial Legal Affairs at a publicly-traded global medical device company prior to joining ZOLL. Her previous experience also includes roles serving as lead counsel in the areas of corporate/finance/M&A, operations and technology transactions in the healthcare industry. She also previously served on the Board and as President of the Association of Corporate Counsel – Western Pennsylvania chapter. Ms. Sinha received her Juris Doctor from Duquesne University of Law and her BA in Economics from the University of Wisconsin-Madison.
 

Christoph Stoeppler

Vice President, Europe, Middle East and Africa Operations

Mr. Stoeppler joined the Company in 2019. He comes to ZOLL with almost 20 years in leadership positions in the healthcare industry, most recently as the Regional Director of Germany, Austria, Switzerland, and Poland for Abbott. Prior to this role, Mr. Stoeppler held various senior leadership roles in St. Jude Medical’s cardiology businesses including cardiac arrhythmia management, structural heart, heart failure, chronic pain, and deep brain stimulation. Mr. Stoeppler received his BS in Biomedical Engineering from University of Giessen-Friedberg in Germany.
 

Jonathan Turner

Vice President, Compliance, Privacy, and Governance

Mr. Turner joined the Company in 2020, after nearly 30 years creating ethics and compliance programs for global technology, medical device, and financial companies. Most recently, Mr. Turner was the Vice President of Compliance for Smith & Nephew, a global medical device and pharmaceutical company, and previously served as Senior Director of Corporate Compliance for Wright Medical Technology, an extremities medical device manufacturer (now part of Stryker). Previously he spent 20 years in consulting roles with various firms and held adjunct faculty roles at Florida State University Law School, the University of North Carolina – Chapel Hill and the University of Memphis. Mr. Turner received his BA in International Relations from Tulane University and MSc in Security & Risk Management from the University of Leicester.
 

Kent Volosin, MD, FACC, FHRS

Vice President, Medical and Clinical Affairs

Dr. Volosin joined the Company in 2016 after more than 25 years of medical practice as a Cardiac Electrophysiologist. In addition to clinical practice, Dr. Volosin has a wide range of experiences with clinical trial development and execution, medical device research and development, and regulatory strategy. Most recently, he was a physician advisor for Shore Medical Center and, previously, was the Director of Cardiac Implantable Devices with Penn Cardiology at the University of Pennsylvania. Dr. Volosin holds a BA in Biology from Rutgers University and an MD from Bowman Gray School of Medicine of Wake Forest University. He completed his internship and residency, cardiology fellowship, and electrophysiology fellowship at Thomas Jefferson University Hospital in Philadelphia, PA.